BA
VCYT icon

Bridgewater Associates’s Veracyte VCYT Stock Holding History

Bridgewater Associates’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.42M Sell
58,289
-33,301
-36% -$1.4M 0.01% 562
2026
Q1 		$2.95M Buy
91,590
+63,196
+223% +$2.34M 0.01% 561
2025
Q4 		$1.2M Buy
+28,394
New +$1.14M ﹤0.01% 855

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bridgewater Associates's VCYT Position: Q2 2026 in Review

Bridgewater Associates reduced its Veracyte (VCYT) stake by 36% in Q2 2026, selling an estimated $1.4M and leaving 58,289 shares worth $3.42M. The position accounts for 0.01% of the portfolio, ranked #562.

Bridgewater Associates first reported a position in VCYT in Q4 2025 and has held it in 3 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Bridgewater Associates held 58,289 shares of Veracyte worth $3.42M as of Q2 2026.
  • Bridgewater Associates sold 33,301 Veracyte shares in Q2 2026, an estimated $1.4M.
  • Veracyte made up 0.01% of Bridgewater Associates's portfolio in Q2 2026, its #562 holding.
  • Bridgewater Associates first reported a position in Veracyte in Q4 2025 and has held it in 3 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.